Quest Diagnostics Introduces Dako's PD-L1 Companion Diagnostic for KEYTRUDAÂ®, Merck's Anti-PD-1 Therapy for Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression On or After Platinum-Cont